This suggests that miR-519d has suppressive effects on ovarian carcinoma by downregulating RhoC, Bcl-2, cyclin D1, survivin, MMP2, MMP9, STAT3 and HuR expression. This evidence concerns the gene BCL2 and ovarian carcinoma.